In another Glasgow, Scotland interview on the Road to 2021, Dxcover (formerly ClincSpec Diagnostics) Founder and CTO Matthew Baker and Co-Founder and CEO Mark Hegarty discuss the future of brain cancer diagnostics.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
OUR MISSION To be a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
.svg)
